Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY20.55 CNY
Change Today -0.10 / -0.48%
Volume 13.7M
600267 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

zhejiang hisun pharmaceuti-a (600267) Snapshot

Open
CNY20.57
Previous Close
CNY20.65
Day High
CNY20.75
Day Low
CNY20.39
52 Week High
03/25/15 - CNY21.38
52 Week Low
05/19/14 - CNY13.53
Market Cap
19.8B
Average Volume 10 Days
21.5M
EPS TTM
CNY0.37
Shares Outstanding
965.5M
EX-Date
06/25/14
P/E TM
55.0x
Dividend
CNY0.11
Dividend Yield
0.54%
Current Stock Chart for ZHEJIANG HISUN PHARMACEUTI-A (600267)

Related News

No related news articles were found.

zhejiang hisun pharmaceuti-a (600267) Related Businessweek News

No Related Businessweek News Found

zhejiang hisun pharmaceuti-a (600267) Details

Zhejiang Hisun Pharmaceutical Co. Ltd. provides various pharmaceutical products and services to patients and its business partners. The company provides antineoplastic, cardiovascular, anti-infection, endocrine control, anti-parasite, anti-tumor, anti-infective, and anti-immunosuppressive drugs, as well as animal remedies and muscle and skeletal system products. It also provides APIs and finished drugs, and medical information and product consulting services. The company markets and distributes its products under the HISUN brand in approximately 70 regions and countries. It has collaboration with Ambrx Inc. to develop and commercialize bispecifics for cancer. The company was founded in 1956 and is headquartered in Taizhou, China.

Founded in 1956

zhejiang hisun pharmaceuti-a (600267) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang hisun pharmaceuti-a (600267) Key Developments

Zhejiang Hisun Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Feb 11, 2015

Zhejiang Hisun Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Feb 11, 2015., at 13:30 China Standard Time. Agenda: To consider the eligibility for public issue of corporate bonds; to consider the scheme for public issue of corporate bonds; to consider the authorization to the board to handle matters in relation to the issuance of corporate bonds; and to consider the change of directors.

Zhejiang Hisun Pharmaceutical Co., Ltd., Board Meeting, Jan 26, 2015

Zhejiang Hisun Pharmaceutical Co., Ltd., Board Meeting, Jan 26, 2015. Agenda: To discuss and approve the proposal of purchasing 68% equity of Yunnan Biological Pharmaceutical Co., Ltd.' to discuss the proposal of public corporate bonds issuance' and to discuss the proposal of changing directors.

Zhejiang Hisun Pharmaceutical Co., Ltd., Board Meeting, Dec 12, 2014

Zhejiang Hisun Pharmaceutical Co., Ltd., Board Meeting, Dec 12, 2014. Agenda: To approve the proposal of providing financial aid for its holding subsidiary; and to consider the proposal of using some idle raised funds to temporarily supplement current capital.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600267:CH CNY20.55 CNY -0.10

600267 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600267.
View Industry Companies
 

Industry Analysis

600267

Industry Average

Valuation 600267 Industry Range
Price/Earnings 54.4x
Price/Sales 1.8x
Price/Book 2.8x
Price/Cash Flow 62.4x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG HISUN PHARMACEUTI-A, please visit www.hisunpharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.